Bottom line
Is GHTMX a good fund? The bottom line
GHTMX is the Institutional share class of Goldman Sachs International Tax-Managed Equity Fund, a managed international stock mutual fund from Goldman Sachs.
Annual fees run 0.9% — about $90 a year on every $10,000 invested, cheaper than 50% of international stock funds we track.
It returned +39.5% over one year, +11.2% a year over five years, +9.3% a year over ten (as of Dec 31, 2025, per its prospectus).
With $958 million in net assets and 301 holdings, its largest position is Asml Holding Nv (3.5%) and the top 10 make up 17% of the portfolio.
What stands out
- 5-year return beat 89% of category peers
- Broadly diversified (301 holdings)
- No front-end sales load
What to watch
- High turnover (175% a year) can mean more taxable distributions
Updated Nov 19, 2026
What GHTMX invests in
The Goldman Sachs International Tax-Managed Equity Fund (the Fund) seeks to provide long-term after-tax growth of capital through tax-sensitive participation in a broadly diversified portfolio of international equity securities.
The Fund invests, under normal circumstances, at least 80% of its net assets plus any borrowings for investment purposes (measured at the time of purchase) (Net Assets) in equity investments in non-U.S. issuers. The Fund seeks broad representation of large-cap and mid-cap issuers across major countries and sectors of the international economy, with some exposure to small-cap issuers. The Fund uses a variety of quantitative techniques, in combination with a qualitative overlay, when selecting investments that have the potential to maximize the Funds after-tax return and minimize capital gains and income distributions. These quantitative techniques, which are derived from fundamental research and based on certain investment themes, including, among others, Fundamental Mispricings, High Quality Business Models, Sentiment Analysis and Market Themes & Trends. Fundamental Mispricings seeks…
From the fund's prospectus (filed Apr 29, 2026).
GHTMX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| GHTMX | +39.5% | +11.2% | +9.3% |
| International Stock median | +25.5% | +6.4% | +7.6% |
Source: Fund prospectus, as of Dec 31, 2025
What GHTMX costs
On a $10,000 investment, GHTMX's 0.9% expense ratio costs about $90 a year. The prospectus estimates $1,183 in total costs over 10 years (assuming 5% annual returns). The median international stock fund charges 0.9%.
GHTMX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Asml Holding Nv ASML | 3.51% |
| 2 | Novartis Ag NOVN | 1.79% |
| 3 | Astrazeneca Plc AZN | 1.72% |
| 4 | Siemens Ag SIE | 1.70% |
| 5 | Murata Manufacturing Company Ltd 6981 | 1.57% |
| 6 | Compagnie Financiere Richemont Sa CFR | 1.46% |
| 7 | Abb Ltd (ch) ABBN | 1.41% |
| 8 | Nestle' Sa/ag NESN | 1.38% |
| 9 | Renesas Electronics Corp 6723 | 1.27% |
| 10 | Safran Sa SAF | 1.21% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 17% of the fund. See all top 25 holdings and asset mix →